2.10Open2.10Pre Close4 Volume4 Open Interest12.50Strike Price825.00Turnover130.67%IV3.79%PremiumMay 16, 2025Expiry Date1.47Intrinsic Value100Multiplier9DDays to Expiry0.53Extrinsic Value100Contract SizeAmericanOptions Type0.7390Delta0.1110Gamma6.99Leverage Ratio-0.0526Theta0.0021Rho5.16Eff Leverage0.0073Vega
Denali Therapeutics Stock Discussion
Clinical Trial Success: Denali's Hunter Syndrome Drug Delivers Game-Changing Patient Improvements
» Holdings in Top 20: 86.71%
» Qtr over Qtr Change**: -9.29%
Top Holdings:
$Incyte (INCY.US)$
$BeiGene (BGNE.US)$
$ACADIA Pharmaceuticals (ACAD.US)$
$Madrigal Pharmaceuticals (MDGL.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Revolution Medicines (RVMD.US)$
$Kymera Therapeutics (KYMR.US)$
$AbCellera Biologics (ABCL.US)$
$Bicycle Therapeutics (BCYC.US)$
$Edgewise Therapeutics (EWTX.US)$
$Immunocore (IMCR.US)$
$Kodiak Sciences (KOD.US)$
$Roivant Sciences (ROIV.US)$